← Eichor
Condition: Liver Ablation Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Liver Ablation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment
NA · 1 location(s) · Shanghai Zhongshan Hospital · NCT06794073Stereotactic Radiosurgery Versus Radiofrequency Ablation for Primary Liver Cancer
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT06766643Microwave Ablation Simultaneously Combined With Lenavatinib for Recurrent Hepatocellular Carcinoma
NA · 1 location(s) · Sun Yat-sen University · NCT05444478Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
Phase N/A · 1 location(s) · Palo Alto Veterans Institute for Research · NCT07303725A Study on the Efficacy and Safety of Multi-mode Ablation Combined With Systemic Therapy in the Treatment of CRCLM
Phase 2 · 1 location(s) · Shanghai 6th People's Hospital · NCT06590259Donafenib as Adjuvant Therapy Following Ablation for Recurrent HCC
NA · 1 location(s) · Sun Yat-sen University · NCT06609876Intravascular Radiofrequency Ablation of Sympathetic Nerves for the Treatment of Hepatocellular Carcinoma
NA · 1 location(s) · Zhongda Hospital · NCT06694636Comparison of Transcutaneous and Arterial Carbon Dioxide Sampling During Jet Ventilation, a Prospective. Study on Patien
Phase N/A · 1 location(s) · Sahlgrenska University Hospital · NCT07211763Computer Guided Microwave Liver Ablation
NA · 2 location(s) · NE Scientific INC · NCT07226869Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLM
Phase 1/Phase 2 · 1 location(s) · M.R. Meijerink · NCT06630624Adjuvant PD-1 Inhibitor for Patients With Early-stage Hepatocellular Carcinoma Following Microwave Ablation
NA · 1 location(s) · Chen Xiaoping · NCT06248554Microwave Ablation Versus Liver Resection for Intrahepatic Cholangiocarcinoma
Phase N/A · 1 location(s) · Chinese PLA General Hospital · NCT06462742Clinical Effectiveness of Microwave Ablation Using Starwave Microwave Generator for Hepatic Malignancies
NA · 1 location(s) · Seoul National University Hospital · NCT06426992Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate Retreatment
Phase 2/Phase 3 · 1 location(s) · Memorial Sloan Kettering Cancer Center · NCT04143516RFA Plus Carrizumab vs Carrizumab Alone for HCC
Phase 2 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT04150744Variability of Microwave Ablation Volume Based on Clinical, Radiological, Biological, and Tissue Factors
Phase N/A · 1 location(s) · Central Hospital, Nancy, France · NCT07413640Ablation in Combination With Lenvatinib and Anti-PD-1 Antibodies
Phase 1 · 1 location(s) · Hua Li · NCT05803928A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
Phase 2 · 9 location(s) · Memorial Sloan Kettering Cancer Center · NCT05657873Prospective Cohort Study on Thermal Ablation of Malignant Liver Tumors
Phase N/A · 1 location(s) · Leiden University Medical Center · NCT06179602The Comparison of TACE-Lenvatinib With TACE-Lenvatinib-ablation for Intermediate Recurrent Hepatocellular Carcinoma
NA · 1 location(s) · Sun Yat-sen University · NCT06609850Evaluation of Tissue and Circulating microRNA Profiles in Patients With Hepatocellular Carcinoma Subjected to Thermal Ab
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT07601464Clinical Study of Multimodal Ablation Remodeling Immunosensitized PD-1 in the Treatment of Pancreatic Cancer With Liver
NA · 1 location(s) · Shanghai General Hospital, Shanghai Jiao Tong University Sch · NCT06307080Ablation With Confirmation of Colorectal Liver Metastases (ACCLAIM)
NA · 7 location(s) · Society of Interventional Oncology · NCT05265169EUS-guided RFA for Solid Abdominal Neoplasms
NA · 1 location(s) · Chinese University of Hong Kong · NCT03221335Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms
Phase N/A · 1 location(s) · Francesco De Cobelli · NCT03981497Y-90 Treatment Response Using Transarterial Radioembolization
Phase 2 · 1 location(s) · Thomas Jefferson University · NCT07145801Comparison of Hepatectomy and Local Ablation for Resectable Synchronous and Metachronous Colorectal Liver Metastasis
NA · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT02886104Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at Hig
Phase 3 · 67 location(s) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT05862337Clinical Study on the Safety, Efficacy, and Exploration of Immune Mechanisms of a Combined Multimodal Tumor Therapy Syst
NA · 1 location(s) · Fudan University · NCT07459309A Study of Standard Of Care Versus Radio Ablation in Early Stage HCC
NA · 2 location(s) · University Health Network, Toronto · NCT07628751
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.